/

Other

/

Veryan Medical

Veryan Medical

Veryan Medical

Verified Nov 2026

Other

·

United Kingdom flag

Horsham, England

·

Since 2003

Veryan Medical, headquartered in Horsham, England, and founded in 2003, develops vascular stents for peripheral arterial disease treatment. The company, which employs 100–200 people, is owned by Otsuka Medical Devices as of December 2018. Its BioMimics 3D Vascular Stent System uses helical geometry to improve blood flow in patients with vascular disease and has received regulatory approval in Europe, the US, and Japan.

Veryan Medical

Verified Nov 2026

AT A GLANCE

Founded

2003

Headquarters

United Kingdom flag

Horsham, England

Employees

100-200

Ownership

Veryan Medical at a glance

Revenue

$10-50M

Est. band

Employees

100-200

Founded

2003

Headquarters

Horsham, England

Certifications

ISO 13485

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

STABILITY SIGNALS

Established & active

23 years in operation (founded 2003).

Holds ISO 13485 certification(s) per public sources.

Overview

Veryan Medical, headquartered in Horsham, England, and founded in 2003, develops vascular stents for peripheral arterial disease treatment. The company, which employs 100–200 people, is owned by Otsuka Medical Devices as of December 2018. Its BioMimics 3D Vascular Stent System uses helical geometry to improve blood flow in patients with vascular disease and has received regulatory approval in Europe, the US, and Japan.

At a glance

Attribute

Detail

Founded

2003

Headquarters

Horsham, England

Employees

100-200

Revenue

$10-50M (estimated)

Certifications

ISO 13485

What Veryan Medical makes

The company holds ISO 13485 certification and manufactures self-expanding nitinol stents, thrombectomy systems, and catheters designed with biomimetic principles for peripheral vascular intervention.

Certifications

Veryan Medical is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

Latest developments

Company details

Veryan is a subsidiary of Otsuka Medical Devices with research and development operations in Galway, Ireland, and serves healthcare providers globally through regulatory-approved interventional cardiovascular devices. Veryan Medical was founded in 2003, has an estimated 100-200 employees, and is headquartered in Horsham, England. On the LightSource stability read it is rated "Established & active": 23 years in operation (founded 2003). Holds ISO 13485 certification(s) per public sources.

Frequently asked questions

What does Veryan Medical do?

Veryan Medical, headquartered in Horsham, England, and founded in 2003, develops vascular stents for peripheral arterial disease treatment. The company, which employs 100–200 people, is owned by Otsuka Medical Devices as of December 2018. Its BioMimics 3D Vascular Stent System uses helical geometry to improve blood flow in patients with vascular disease and has received regulatory approval in Europe, the US, and Japan.

Where is Veryan Medical headquartered?

Veryan Medical is headquartered in Horsham, England.

When was Veryan Medical founded?

Veryan Medical was founded in 2003.

How big is Veryan Medical?

Veryan Medical has an estimated 100-200 employees, with revenue in the $10-50M range (estimated).

What certifications does Veryan Medical hold?

Veryan Medical lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Horsham, England (HQ)Headquarters · England, United Kingdom
Horsham, England (HQ)Horsham, England, United KingdomHeadquarters

Phone

'+44 140 325 8984

Certification

ISO 13485

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.